Ketotifen Hydrogen Fumarate Aurobindo (Ketotifen Hydrogen Fumarate)

Ketotifen selectively antagonises histamine H1 receptors, preventing histamine‑mediated allergic responses. In addition, it stabilises mast cells, limiting the release of histamine, leukotrienes and other inflammatory mediators. This dual action reduces nasal, ocular and bronchial inflammation associated with allergic disease.

The appropriate dose of ketotifen is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms and clinical response. Dosage forms and regimens may vary, and patients should follow the prescriber’s instructions without self‑adjusting the dose.

Safety data for ketotifen during pregnancy and lactation are limited. It should only be used when the potential benefit outweighs any possible risk to the fetus, and caution is advised for nursing mothers because the drug can be excreted in breast milk. Consultation with a healthcare provider is essential.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with many first‑generation antihistamines, ketotifen offers both H1‑receptor blockade and mast‑cell stabilisation, providing additional benefit for asthma prophylaxis. While it may cause more sedation than some second‑generation agents, its dual mechanism can be advantageous for patients with combined nasal, ocular and bronchial allergic symptoms.

Ketotifen should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Ketotifen is taken orally, usually as a tablet or syrup, as directed by the prescriber. It should be swallowed with water and may be taken with or without food, depending on the specific formulation and the clinician’s recommendation.

Although rare, serious adverse reactions can include cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, hepatotoxicity, and anaphylaxis. Patients experiencing any of these symptoms should seek immediate medical attention.

Ketotifen is contraindicated in individuals with known hypersensitivity to the drug or any of its components. Caution is also advised for patients with severe cardiac disease, uncontrolled asthma, or those taking interacting medications listed under major interactions. Consultation with a healthcare professional is required before initiating therapy.